Applications of pharmaceutical composition in preparation of drugs used for treating osteoporosis

A technology of osteoporosis and composition, which is applied in the field of traditional Chinese medicine, can solve the problems of palliative treatment, not the root cause, and easy recurrence, and achieve the effect of definite curative effect, no toxic side effects, and strong penetration

Inactive Publication Date: 2016-03-16
JINAN UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Chinese patent CN103083638B discloses a medicament for treating osteoporosis, which is prepared by a certain weight ratio from veratrum, salvia miltiorrhi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of pharmaceutical composition in preparation of drugs used for treating osteoporosis
  • Applications of pharmaceutical composition in preparation of drugs used for treating osteoporosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] The pharmaceutical composition of Example 1 of the present invention is prepared from the following raw materials in parts by weight:

[0041] 17 parts of mugwort leaves, 15 parts of chickpeas, 16 parts of epimedium, 13 parts of Eucommia, 14 parts of Polygonatum, 12 parts of citron, 10 parts of astragalus, 11 parts of woody fragrance, 10 parts of Milletah, 7 parts of black soybean, mulberry 8 parts of leaves and 6 parts of licorice.

[0042] Preparation:

[0043] S1. Weigh each medicinal material according to the prescription of the traditional Chinese medicine, and pulverize it for later use;

[0044] S2. Add distilled water 5 times the weight of the above-mentioned coarse powder to the coarse powder in step S1, soak for 20 hours, decoct for 2 hours, filter and retain the filtrate; add purified water 4 times the weight of the above-mentioned filter residue, and decoct for 1 hour. Filter and retain the filter residue; combine the filtrates and concentrate to a concent...

Embodiment 2

[0048] The pharmaceutical composition of Example 2 of the present invention is prepared from the following raw materials in parts by weight:

[0049] 20 parts of mugwort leaf, 18 parts of chickpea, 18 parts of epimedium, 17 parts of Eucommia, 17 parts of sealwort, 15 parts of citron, 13 parts of astragalus, 14 parts of woody fragrance, 13 parts of Milletus spathula, 11 parts of black soybean, mulberry 11 parts of leaves and 9 parts of licorice.

[0050] Preparation method: with embodiment 1.

Embodiment 3

[0052] The pharmaceutical composition of Example 3 of the present invention is prepared from the following raw materials in parts by weight:

[0053] 24 parts of mugwort leaves, 20 parts of chickpeas, 21 parts of epimedium, 20 parts of Eucommia, 20 parts of Polygonatum, 18 parts of citron, 16 parts of astragalus, 17 parts of woody fragrance, 16 parts of Milletweed, 15 parts of black soybean, mulberry 13 parts of leaves and 13 parts of licorice.

[0054] Preparation method: with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of traditional Chinese medicine, and relates to applications of a pharmaceutical composition in preparation of drugs used for treating osteoporosis. The pharmaceutical composition is mainly prepared from, by weight, 17 to 24 parts of folium artemisiae argyi, 15 to 20 parts of cicer arietinum, 16 to 21 parts of herba epimedii, 13 to 20 parts of cortex eucommiae, 14 to 20 parts of rhizoma polygonati, 12 to 18 parts of fructus citri, 10 to 16 parts of astragalus membranaceus, 11 to 17 parts of radix aucklandiae, 10 to 16 parts of caulis spatholobi, 7 to 15 parts of black soybean, 8 to 13 parts of folium mori, and 6 to 13 parts of liquorice. The pharmaceutical composition is capable of replenishing blood and activating blood circulation, strengthening bone and relieving pain, nourishing liver and kidney, and loosening bones and muscles, and possesses excellent permeability and pertinency; effects are achieved quickly; no disease recurrence is caused; application of the pharmaceutical composition is convenient; and no side or toxic effect is caused.

Description

Technical field [0001] The present invention is a Chinese medicine field, which involves the purpose of a drug combination to prepare in the treatment of osteoporosis drugs. Background technique [0002] Osteoporosis is osteoporosis. It is a group of bone disease caused by multiple reasons. Bone tissue has normal calcification. Calcium salt and matrix are proportional.EssenceIn most osteoporosis, the reduction of bone tissue is mainly due to increased bone absorption.Bone pain and easy fracture.The onset of the disease is slow, and it is very fast. It is characterized by bone pain and easy to fracture. Biochemical examination is basically normal.The most common symptoms of primary osteoporosis are more common in back pain, accounting for 70 % to 80 % of patients with pain.Pain spreads along the spine to both sides, and the pain is reduced when lying on or sitting. The pain is extended or stretched back for a long time when standing upright. [0003] Traditional Chinese medicine b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61P19/10
CPCA61K36/282A61K9/06A61K36/285A61K36/296A61K36/46A61K36/48A61K36/481A61K36/484A61K36/486A61K36/605A61K36/752A61K36/8969A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 王一飞郑丹琳任哲刘秋英利奕成
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap